We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
-13.16%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.18B
AUM Growth
-$93.5M
Cap. Flow
+$113M
Cap. Flow %
9.6%
Top 10 Hldgs %
21.21%
Holding
341
New
184
Increased
50
Reduced
82
Closed
18

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$12.6M
2
MFC icon
Manulife Financial
MFC
+$7.56M
3
GKOS icon
Glaukos
GKOS
+$7.01M
4
AMZN icon
Amazon
AMZN
+$6.67M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.26M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$11.7M
2
UNH icon
UnitedHealth
UNH
+$11.3M
3
IRTC icon
iRhythm Holdings
IRTC
+$9.63M
4
HALO icon
Halozyme
HALO
+$8.33M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$7.47M

Sector Composition

Rank Sector Weight
1 Healthcare 46.65%
2 Financials 13.97%
3 Consumer Discretionary 13.94%
4 Technology 8.36%
5 Industrials 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
1
Thermo Fisher Scientific
TMO
$222B
$28.8M 2.44%
52,995
-4,596
-8% -$2.53M
SCI icon
2
Service Corp International
SCI
$11.4B
$27.6M 2.34%
400,000
-50,000
-11% -$3.42M
CVS icon
3
CVS Health
CVS
$122B
$27.4M 2.32%
295,169
-41,298
-12% -$4.03M
MED icon
4
Medifast
MED
$135M
$27.1M 2.29%
150,000
-25,000
-14% -$4.47M
IQV icon
5
IQVIA
IQV
$39.8B
$26.5M 2.24%
122,124
-17,439
-12% -$3.79M
LHCG
6
DELISTED
LHC Group LLC
LHCG
$25.7M 2.18%
165,000
-35,000
-18% -$5.77M
BMY icon
7
Bristol-Myers Squibb
BMY
$132B
$22.6M 1.91%
293,631
-64,667
-18% -$4.93M
UNH icon
8
UnitedHealth
UNH
$371B
$22.3M 1.89%
43,431
-22,525
-34% -$11.3M
AMP icon
9
Ameriprise Financial
AMP
$49.2B
$21.5M 1.82%
90,448
-530
-0.6% -$142K
CIXX
10
DELISTED
CI Financial Corp.
CIXX
$21.1M 1.78%
2,000,000
+250,000
+14% +$3.16M
BNTX icon
11
BioNTech
BNTX
$23.3B
$21M 1.78%
140,958
+21,647
+18% +$3.31M
NBIX icon
12
Neurocrine Biosciences
NBIX
$16.8B
$21M 1.77%
214,930
+24,362
+13% +$2.25M
HOLX
13
DELISTED
Hologic
HOLX
$20.9M 1.77%
302,309
-41,516
-12% -$3.08M
INCY icon
14
Incyte
INCY
$24.6B
$20.8M 1.76%
273,821
-58,677
-18% -$4.46M
BMRN icon
15
BioMarin Pharmaceuticals
BMRN
$13.3B
$20.8M 1.76%
250,517
-41,353
-14% -$3.29M
ABBV icon
16
AbbVie
ABBV
$438B
$20.8M 1.76%
135,486
-76,474
-36% -$11.7M
THO icon
17
Thor Industries
THO
$4.14B
$20.6M 1.74%
275,000
– –
V icon
18
Visa
V
$675B
$20.1M 1.7%
102,102
-20,760
-17% -$4.29M
DXCM icon
19
DexCom
DXCM
$33.1B
$19.6M 1.66%
262,864
+137,808
+110% +$12.6M
LH icon
20
Labcorp
LH
$26.1B
$18.9M 1.6%
93,953
-11,640
-11% -$2.48M
HALO icon
21
Halozyme
HALO
$11.6B
$18.5M 1.57%
421,403
-192,687
-31% -$8.33M
LOW icon
22
Lowe's Companies
LOW
$123B
$18.4M 1.56%
105,480
+1,164
+1% +$224K
ABT icon
23
Abbott
ABT
$188B
$18.3M 1.55%
168,777
+11,285
+7% +$1.28M
BC icon
24
Brunswick
BC
$5.21B
$18M 1.52%
275,000
-35,037
-11% -$2.58M
ELS icon
25
Equity Lifestyle Properties
ELS
$12.5B
$17.6M 1.49%
250,000
-50,000
-17% -$3.73M
1
2 3 4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
WCA
Waratah Capital Advisors Toronto, Ontario, Canada $2.63B AUM 76.33% 1-Year Est. Return
NIG
NFJ Investment Group Dallas, Texas $2.64B AUM 23.86% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q2 2022 Portfolio in Review

As of Q2 2022, Lombard Odier Asset Management (Switzerland) held 341 positions worth $1.18B, down 7.3% from $1.27B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lombard Odier Asset Management (Switzerland) deployed $113M of net new capital in Q2 2022, opening 184 new positions and adding to 50 existing holdings. Its largest new stake was Glaukos: 147,742 shares worth $6.71M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 57% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $11.7M trimmed.

  • Lombard Odier Asset Management (Switzerland)'s largest Q2 2022 buy was Glaukos: 147,742 shares worth $6.71M.
  • Lombard Odier Asset Management (Switzerland) added most to DexCom in Q2 2022, an estimated $12.6M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q2 2022 reduction was AbbVie, cutting an estimated $11.7M.
  • Lombard Odier Asset Management (Switzerland) fully exited G1 Therapeutics, Inc. Common Stock in Q2 2022, selling an estimated $4.12M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 21% of its $1.18B portfolio in Q2 2022.
  • Lombard Odier Asset Management (Switzerland) opened 184 new positions and closed 18 in Q2 2022.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 7.3% quarter-over-quarter to $1.18B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 15 Aug 2022.